0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Dr. Smith and Colleagues Reply
WARD T. SMITH, M.D.; PETER D. LONDBORG, M.D.; VINCENT GLAUDIN, PH.D.; JOHN R. PAINTER, PH.D.
Am J Psychiatry 1999;156:1840-a-1840.
text A A A

To the Editor: Dr. Furukawa is justified in calling our attention to negative results in some studies of benzodiazepine when used as monotherapy or to augment tricyclic antidepressant therapy in the treatment of major depression. In retrospect, it may have been desirable to broaden the context of our study of clonazepam’s augmentation of fluoxetine, as he suggested, although it was not our intention to present a comprehensive review of the literature. Instead, we wished to point to some successes in the use of benzodiazepine in treating depression as a part of the basis for extending this practice to the augmentation of selective serotonin reuptake inhibitors. We are not advocating a return to benzodiazepine augmentation of tricyclic antidepressants nor do we recommend benzodiazepine monotherapy in treating depression, even though the latter is not uncommon and may often be successful—for example, when agitated depression has been misdiagnosed as an anxiety disorder. Our highlighting of some positive results of benzodiazepine therapy in the treatment of depression served as a prelude to our research with clonazepam and suggested a more attractive risk-reward ­ratio concerning this class of drugs. It is our view that, on balance, contemporary negative consensus about the use of benzodiazepines in the treatment of depression has been ­excessive.

+

References

+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 53.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 1.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 2.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 12.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 30.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles